UBS Group’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $433 | Sell |
181
-99
| -35% | -$237 | ﹤0.01% | 8500 |
|
|
2025
Q1 | $1.2K | Sell |
280
-1,933
| -87% | -$8.31K | ﹤0.01% | 8236 |
|
|
2024
Q4 | $19K | Buy |
2,213
+2,094
| +1,760% | +$18K | ﹤0.01% | 6679 |
|
|
2024
Q3 | $2.02K | Sell |
119
-1,000
| -89% | -$17K | ﹤0.01% | 7302 |
|
|
2024
Q2 | $16.9K | Sell |
1,119
-69
| -6% | -$1.04K | ﹤0.01% | 6261 |
|
|
2024
Q1 | $19.7K | Sell |
1,188
-457
| -28% | -$7.58K | ﹤0.01% | 5763 |
|
|
2023
Q4 | $26.3K | Sell |
1,645
-1,227
| -43% | -$19.6K | ﹤0.01% | 5722 |
|
|
2023
Q3 | $219K | Sell |
2,872
-3,484
| -55% | -$265K | ﹤0.01% | 4213 |
|
|
2023
Q2 | $417K | Buy |
6,356
+1,060
| +20% | +$69.5K | ﹤0.01% | 3969 |
|
|
2023
Q1 | $317K | Sell |
5,296
-459
| -8% | -$27.4K | ﹤0.01% | 4016 |
|
|
2022
Q4 | $134K | Sell |
5,755
-5
| -0.1% | -$116 | ﹤0.01% | 4711 |
|
|
2022
Q3 | $193K | Buy |
5,760
+305
| +6% | +$10.2K | ﹤0.01% | 4092 |
|
|
2022
Q2 | $145K | Buy |
5,455
+5,348
| +4,998% | +$142K | ﹤0.01% | 4167 |
|
|
2022
Q1 | $3K | Sell |
107
-159
| -60% | -$4.46K | ﹤0.01% | 8444 |
|
|
2021
Q4 | $23K | Buy |
+266
| New | +$23K | ﹤0.01% | 6574 |
|